Minapharm’s consolidated profit drops 37% in 9 months
Minapharm Pharmaceuticals saw its profit dropping by 37% year-on-year
By Staff Writer, Mubasher
Cairo – Mubasher:Minapharm Pharmaceuticals saw its profit dropping by 37% year-on-year in the first nine months of 2019, the drugmaker’s consolidated financial results showed on Thursday.
Net profit fell to EGP 73.9 million ($4.59 million) in the period between January and September, compared with EGP 117.39 million in the year-before period, according to the company’s statement to the Egyptian Exchange (EGX).
The EGX-listed firm recorded EGP 1.503 billion in revenues over the nine-month period, slightly lower than EGP 1.505 billion a year ago.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW